A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CASTRO, Talita et al. Polyomavirus BK and JC in individuals with chronic kidney failure, kidney transplantation, and healthy controls. Journal of Clinical Virology, v. 89, p. 5–9, 2017Tradução . . Acesso em: 01 jun. 2023.
APA
Castro, T., Fink, M. C. D. da S., Figueiredo, M. I., Braz-Silva, P. H., Pannuti, C. M., Ortega, K. L., & Gallottini, M. H. C. (2017). Polyomavirus BK and JC in individuals with chronic kidney failure, kidney transplantation, and healthy controls. Journal of Clinical Virology, 89, 5–9. doi:http://dx.doi.org/10.1016/j.jcv.2017.02.003
NLM
Castro T, Fink MCD da S, Figueiredo MI, Braz-Silva PH, Pannuti CM, Ortega KL, Gallottini MHC. Polyomavirus BK and JC in individuals with chronic kidney failure, kidney transplantation, and healthy controls. Journal of Clinical Virology. 2017 ; 89 5–9.[citado 2023 jun. 01 ]
Vancouver
Castro T, Fink MCD da S, Figueiredo MI, Braz-Silva PH, Pannuti CM, Ortega KL, Gallottini MHC. Polyomavirus BK and JC in individuals with chronic kidney failure, kidney transplantation, and healthy controls. Journal of Clinical Virology. 2017 ; 89 5–9.[citado 2023 jun. 01 ]
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DAVID-NETO, Elias et al. A double-blinded, prospective study to define antigenemia and quantitative real time polymerase chain reaction cutoffs to start preemptive therapy in low-risk, seropositive, renal transplanted recipients. Clinical and Transplantation Research, v. 98, n. 10, p. 1077-1081, 2014Tradução . . Disponível em: doi: 10.1097/TP.0000000000000189. Acesso em: 01 jun. 2023.
APA
David-Neto, E., Triboni, A. H. K., Paula, F. J., Vilas Boas, L. S., Machado, C. M., Agena, F., et al. (2014). A double-blinded, prospective study to define antigenemia and quantitative real time polymerase chain reaction cutoffs to start preemptive therapy in low-risk, seropositive, renal transplanted recipients. Clinical and Transplantation Research, 98( 10), 1077-1081. Recuperado de doi: 10.1097/TP.0000000000000189
NLM
David-Neto E, Triboni AHK, Paula FJ, Vilas Boas LS, Machado CM, Agena F, Latif AZA, Alencar CS, Pierrotti LC, Nahas WC, Caiaffa-Filho HH, Pannuti CS. A double-blinded, prospective study to define antigenemia and quantitative real time polymerase chain reaction cutoffs to start preemptive therapy in low-risk, seropositive, renal transplanted recipients [Internet]. Clinical and Transplantation Research. 2014 ; 98( 10): 1077-1081.[citado 2023 jun. 01 ] Available from: doi: 10.1097/TP.0000000000000189
Vancouver
David-Neto E, Triboni AHK, Paula FJ, Vilas Boas LS, Machado CM, Agena F, Latif AZA, Alencar CS, Pierrotti LC, Nahas WC, Caiaffa-Filho HH, Pannuti CS. A double-blinded, prospective study to define antigenemia and quantitative real time polymerase chain reaction cutoffs to start preemptive therapy in low-risk, seropositive, renal transplanted recipients [Internet]. Clinical and Transplantation Research. 2014 ; 98( 10): 1077-1081.[citado 2023 jun. 01 ] Available from: doi: 10.1097/TP.0000000000000189